| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.065 | 0.2 |